← Back
$NUVB All transactions

Nuvation Bio Inc.

▼ SELL

$ Value

$1.4M

Shares

200,000

Price

$7

Filed

Nov 21

Insider

Name

Hanley David C.

Title

CHIEF TECHNICAL OPERATIONS

CIK

0001865826

Roles

Officer

Transaction Details

Transaction Date

2025-11-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,000

Footnotes

Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Filing Info

Accession No.

0001865826-25-000004

Form Type

4

Issuer CIK

0001811063

Hanley David C.'s History

Date Ticker Type Value
2026-02-27 NUVB A $0
2025-11-19 NUVB M $374K
2025-11-19 NUVB $1.4M
2025-11-19 NUVB M $0

Other Insiders at NUVB (90d)

Insider Bought Sold Last
Hung David
PRESIDENT AND CEO
2026-02-27
Wentworth Kerry
CHIEF REGULATORY OFFICER
$1.1M 2026-04-17
Cui Xiangmin 2026-02-27
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
2026-02-27
Markel Stacy
CHIEF PEOPLE OFFICER
2026-02-27
Hanley David C.
CHIEF TECHNICAL OPERATIONS
2026-02-27
Liu Dongfang
CHIEF MEDICAL OFFICER
$251K 2026-04-17
Makunje Moses
SEE REMARKS
2026-02-27
Sjogren Colleen
Chief Commercial Officer
2026-02-27
Sauvage Philippe
Chief Financial Officer
2026-02-27